vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.

Sprout Social, Inc. is the larger business by last-quarter revenue ($120.9M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 12.9%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $9.9M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.8%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.

PBYI vs SPT — Head-to-Head

Bigger by revenue
SPT
SPT
1.6× larger
SPT
$120.9M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+14.8% gap
PBYI
27.7%
12.9%
SPT
More free cash flow
PBYI
PBYI
$4.5M more FCF
PBYI
$14.4M
$9.9M
SPT
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
11.8%
SPT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
SPT
SPT
Revenue
$75.5M
$120.9M
Net Profit
Gross Margin
69.3%
77.6%
Operating Margin
22.7%
-9.0%
Net Margin
Revenue YoY
27.7%
12.9%
Net Profit YoY
EPS (diluted)
$0.26
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SPT
SPT
Q4 25
$75.5M
$120.9M
Q3 25
$54.5M
$115.6M
Q2 25
$52.4M
$111.8M
Q1 25
$46.0M
$109.3M
Q4 24
$59.1M
$107.1M
Q3 24
$80.5M
$102.6M
Q2 24
$47.1M
$99.4M
Q1 24
$43.8M
$96.8M
Net Profit
PBYI
PBYI
SPT
SPT
Q4 25
Q3 25
$8.8M
$-9.4M
Q2 25
$5.9M
$-12.0M
Q1 25
$3.0M
$-11.2M
Q4 24
Q3 24
$20.3M
$-17.1M
Q2 24
$-4.5M
$-16.9M
Q1 24
$-4.8M
$-13.6M
Gross Margin
PBYI
PBYI
SPT
SPT
Q4 25
69.3%
77.6%
Q3 25
77.7%
77.7%
Q2 25
76.5%
77.7%
Q1 25
77.1%
77.3%
Q4 24
76.4%
78.1%
Q3 24
63.9%
77.4%
Q2 24
77.4%
77.5%
Q1 24
75.5%
76.8%
Operating Margin
PBYI
PBYI
SPT
SPT
Q4 25
22.7%
-9.0%
Q3 25
17.6%
-7.9%
Q2 25
12.7%
-11.0%
Q1 25
8.7%
-10.2%
Q4 24
22.6%
-12.8%
Q3 24
27.4%
-16.4%
Q2 24
-4.6%
-16.6%
Q1 24
-5.3%
-13.7%
Net Margin
PBYI
PBYI
SPT
SPT
Q4 25
Q3 25
16.2%
-8.1%
Q2 25
11.2%
-10.7%
Q1 25
6.5%
-10.3%
Q4 24
Q3 24
25.2%
-16.6%
Q2 24
-9.6%
-17.0%
Q1 24
-11.0%
-14.0%
EPS (diluted)
PBYI
PBYI
SPT
SPT
Q4 25
$0.26
$-0.18
Q3 25
$0.17
$-0.16
Q2 25
$0.12
$-0.21
Q1 25
$0.06
$-0.19
Q4 24
$0.40
$-0.25
Q3 24
$0.41
$-0.30
Q2 24
$-0.09
$-0.30
Q1 24
$-0.10
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SPT
SPT
Cash + ST InvestmentsLiquidity on hand
$97.5M
$95.3M
Total DebtLower is stronger
$22.7M
$40.0M
Stockholders' EquityBook value
$130.3M
$203.4M
Total Assets
$216.3M
$523.1M
Debt / EquityLower = less leverage
0.17×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SPT
SPT
Q4 25
$97.5M
$95.3M
Q3 25
$94.4M
$90.6M
Q2 25
$96.0M
$101.5M
Q1 25
$93.2M
$100.9M
Q4 24
$101.0M
$86.4M
Q3 24
$96.7M
$82.9M
Q2 24
$96.8M
$80.9M
Q1 24
$107.2M
$69.2M
Total Debt
PBYI
PBYI
SPT
SPT
Q4 25
$22.7M
$40.0M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
$25.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
SPT
SPT
Q4 25
$130.3M
$203.4M
Q3 25
$115.3M
$194.1M
Q2 25
$104.7M
$184.6M
Q1 25
$97.1M
$175.3M
Q4 24
$92.1M
$166.6M
Q3 24
$71.1M
$158.1M
Q2 24
$48.5M
$152.1M
Q1 24
$51.0M
$147.3M
Total Assets
PBYI
PBYI
SPT
SPT
Q4 25
$216.3M
$523.1M
Q3 25
$202.9M
$481.4M
Q2 25
$194.9M
$422.9M
Q1 25
$196.2M
$424.7M
Q4 24
$213.3M
$428.3M
Q3 24
$220.7M
$388.8M
Q2 24
$205.0M
$393.6M
Q1 24
$214.1M
$389.9M
Debt / Equity
PBYI
PBYI
SPT
SPT
Q4 25
0.17×
0.20×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
0.15×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SPT
SPT
Operating Cash FlowLast quarter
$14.4M
$10.9M
Free Cash FlowOCF − Capex
$14.4M
$9.9M
FCF MarginFCF / Revenue
19.1%
8.2%
Capex IntensityCapex / Revenue
0.0%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$39.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SPT
SPT
Q4 25
$14.4M
$10.9M
Q3 25
$9.7M
$9.3M
Q2 25
$14.1M
$5.1M
Q1 25
$3.6M
$18.1M
Q4 24
$15.6M
$4.1M
Q3 24
$11.0M
$9.0M
Q2 24
$1.0M
$2.1M
Q1 24
$11.2M
$11.2M
Free Cash Flow
PBYI
PBYI
SPT
SPT
Q4 25
$14.4M
$9.9M
Q3 25
$9.7M
$8.5M
Q2 25
$14.1M
$4.2M
Q1 25
$3.6M
$16.7M
Q4 24
$15.6M
$3.3M
Q3 24
$11.0M
$8.5M
Q2 24
$1.0M
$1.6M
Q1 24
$10.1M
FCF Margin
PBYI
PBYI
SPT
SPT
Q4 25
19.1%
8.2%
Q3 25
17.7%
7.4%
Q2 25
26.8%
3.7%
Q1 25
7.7%
15.3%
Q4 24
26.4%
3.0%
Q3 24
13.7%
8.3%
Q2 24
2.1%
1.6%
Q1 24
10.4%
Capex Intensity
PBYI
PBYI
SPT
SPT
Q4 25
0.0%
0.9%
Q3 25
0.0%
0.7%
Q2 25
0.0%
0.8%
Q1 25
0.1%
1.2%
Q4 24
0.0%
0.8%
Q3 24
0.0%
0.5%
Q2 24
0.0%
0.5%
Q1 24
0.0%
1.1%
Cash Conversion
PBYI
PBYI
SPT
SPT
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons